• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

[结直肠结外NK/T细胞淋巴瘤的临床特征及预后分析]

[Clinical features and prognostic analysis of colorectal extranodal NK/T cell lymphoma].

作者信息

Li X Y, Yao J N, Dong X Y, Cheng L X, Zhang X X, Su M G, Zhou H N, Xie J L, Song Z X, Han F

机构信息

Department of Gastroenterology, the First affiliated Hospital of Zhengzhou University, Zhengzhou 450052, China.

出版信息

Zhonghua Zhong Liu Za Zhi. 2024 Aug 23;46(8):782-793. doi: 10.3760/cma.j.cn112152-20231026-00260.

DOI:10.3760/cma.j.cn112152-20231026-00260
PMID:39143801
Abstract

To investigate the clinical manifestations, endoscopic characteristics, and prognostic factors of patients with colorectal extranodal NK/T cell lymphoma. The clinical data of 52 patients with colorectal extranodal NK/T cell lymphoma admitted to the First Affiliated Hospital of Zhengzhou University from January 2013 to January 2023 were retrospectively analyzed. Their clinical manifestations and endoscopic characteristics were summarized, and the prognostic factors were analyzed by Cox regression model. Among the 52 patients with colorectal extranodal NK/T cell lymphoma, there were 35 males and 17 females, with a male-to-female ratio of 2.06∶1. Among the general symptoms, abdominal pain was the most common (39 cases), and B symptoms occurred in 47 patients, among which fever was the most common lymphoma B symptom (42 cases), and gastrointestinal perforation was the most common complication (18 cases). Forty-three patients underwent colonoscopy, and the main manifestations under endoscopy were the ulceration type (24 cases). The ulcers were irregular at the edges and often covered with moss at the bottom. The median survival time was 4.3 months. Multivariate Cox regression analysis showed that hemocytic syndrome (=8.50,95% : 1.679-8.328,=0.001), serum albumin (=3.59,95% : 1.017-6.551, =0.048), and with or without chemotherapy (=0.31, 95% : 0.246-1.061, =0.025) were independent factors influencing the overall survival of patients with colorectal extranodal NK/T cell lymphoma. Colorectal extranodal NK/T cell lymphoma is a rare disease with a very poor prognosis. When patients present with abdominal pain and lymphoma B symptoms, and when ulcers with irregular edges and moss covering the bottom are found under endoscopy, the disease should be considered, and endoscopic biopsy should be taken in time for pathological diagnosis. The prognosis of patients with hemophagocytic syndrome and hypoproteinemia is poor. This disease should be treated with chemotherapy and surgery, and on this basis, hemophagocytic syndrome and hypoproteinemia should be treated to improve the prognosis of patients.

摘要

探讨结直肠结外NK/T细胞淋巴瘤患者的临床表现、内镜特征及预后因素。回顾性分析2013年1月至2023年1月郑州大学第一附属医院收治的52例结直肠结外NK/T细胞淋巴瘤患者的临床资料。总结其临床表现及内镜特征,并采用Cox回归模型分析预后因素。52例结直肠结外NK/T细胞淋巴瘤患者中,男性35例,女性17例,男女比例为2.06∶1。一般症状中,腹痛最为常见(39例),47例出现B症状,其中发热是最常见的淋巴瘤B症状(42例),胃肠道穿孔是最常见的并发症(18例)。43例患者接受了结肠镜检查,内镜下主要表现为溃疡型(24例)。溃疡边缘不规则,底部常覆有苔。中位生存时间为4.3个月。多因素Cox回归分析显示,血细胞综合征(=8.50,95%:1.679 - 8.328,=0.001)、血清白蛋白(=3.59,95%:1.017 - 6.551,=0.048)以及是否接受化疗(=0.31,95%:0.246 - 1.061,=0.025)是影响结直肠结外NK/T细胞淋巴瘤患者总生存的独立因素。结直肠结外NK/T细胞淋巴瘤是一种罕见病,预后很差。当患者出现腹痛及淋巴瘤B症状,且内镜下发现边缘不规则、底部覆有苔的溃疡时,应考虑该病,并及时行内镜活检进行病理诊断。伴有噬血细胞综合征及低蛋白血症的患者预后较差。本病应采用化疗及手术治疗,在此基础上,应对噬血细胞综合征及低蛋白血症进行治疗以改善患者预后。

相似文献

1
[Clinical features and prognostic analysis of colorectal extranodal NK/T cell lymphoma].[结直肠结外NK/T细胞淋巴瘤的临床特征及预后分析]
Zhonghua Zhong Liu Za Zhi. 2024 Aug 23;46(8):782-793. doi: 10.3760/cma.j.cn112152-20231026-00260.
2
[Prognosis and treatment strategies of primary B-cell and NK/T-cell nasopharyngeal non-Hodgkin's lymphoma at early stage].[原发性B细胞和NK/T细胞早期鼻咽非霍奇金淋巴瘤的预后及治疗策略]
Ai Zheng. 2006 Dec;25(12):1543-9.
3
Clinical features and survival of extranodal natural killer/T cell lymphoma with and without hemophagocytic syndrome.伴有和不伴有噬血细胞综合征的结外自然杀伤/T细胞淋巴瘤的临床特征与生存情况
Ann Hematol. 2016 Dec;95(12):2023-2031. doi: 10.1007/s00277-016-2805-9. Epub 2016 Sep 6.
4
Elevated expression of HMGB1 is prognostic of poor survival in patients with relapsed/refractory T/NK-CL.HMGB1 的高表达与复发/难治性 T/NK-CL 患者的不良预后相关。
Ann Hematol. 2021 Sep;100(9):2293-2302. doi: 10.1007/s00277-021-04473-4. Epub 2021 May 15.
5
Extranodal NK/T-cell lymphoma, nasal type: Clinical features, outcome, and prognostic factors in 101 cases.结外 NK/T 细胞淋巴瘤,鼻型:101 例的临床特征、结局和预后因素。
Eur J Haematol. 2018 Sep;101(3):379-388. doi: 10.1111/ejh.13126. Epub 2018 Jul 27.
6
Prognostic characteristics of gastrointestinal tract NK/T-cell lymphoma: an analysis of 47 patients in China.中国 47 例胃肠道 NK/T 细胞淋巴瘤患者的预后特征分析。
J Clin Gastroenterol. 2013 Sep;47(8):e74-9. doi: 10.1097/MCG.0b013e31829e444f.
7
A clinical study of 21 patients with hemophagocytic syndrome in 295 cases diagnosed with nasal type, extranodal nature killer/T cell lymphoma.对295例诊断为鼻型、结外自然杀伤/ T细胞淋巴瘤患者中的21例噬血细胞综合征患者进行的临床研究。
Cancer Biol Ther. 2017 Apr 3;18(4):252-256. doi: 10.1080/15384047.2017.1295176. Epub 2017 Feb 25.
8
Using etoposide + dexamethasone-based regimens to treat nasal type extranodal natural killer/T-cell lymphoma-associated hemophagocytic lymphohistiocytosis.采用依托泊苷+地塞米松为基础的方案治疗鼻型结外 NK/T 细胞淋巴瘤相关噬血细胞性淋巴组织细胞增多症。
J Cancer Res Clin Oncol. 2021 Mar;147(3):863-869. doi: 10.1007/s00432-020-03376-7. Epub 2020 Oct 6.
9
[Clinical characteristics and survival analysis of primary intestinal extranodal NK/T-cell lymphoma, nasal type].[鼻型原发性肠道结外NK/T细胞淋巴瘤的临床特征及生存分析]
Zhonghua Xue Ye Xue Za Zhi. 2020 Oct 14;41(10):818-821. doi: 10.3760/cma.j.issn.0253-2727.2020.10.005.
10
Clinical characteristics of primary intestinal NK/T cell lymphoma, nasal type: Case series and review of the literature.鼻型原发性肠道NK/T细胞淋巴瘤的临床特征:病例系列及文献综述
Pathol Res Pract. 2018 Aug;214(8):1081-1086. doi: 10.1016/j.prp.2018.05.013. Epub 2018 May 25.